More information: Bo Tian et al, Dysregulated inclusion of BOLA3 exon 3 promoted by HNRNPC accelerates the progression of esophageal squamous cell carcinoma, Frontiers of Medicine (2024). DOI: 10. ...

Figure 1. The frequency and distribution of cancer susceptibility genes (CSGs) with more than one pathogenic/likely pathogenic germline mutation detected in patients with esophageal squamous cell ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

We investigated its biological function and clinical significance in esophageal squamous cell carcinoma (ESCC). Design Immunoblotting and immunochemistry were used to determine TBL1XR1 expression in ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

The following drugs are approved in the treatment of advanced esophageal cancer, and those who have specific types of the disease may have improved survival rates. Keytruda (generic name pembrolizumab ...

Symptoms and treatment options depend on the stage of your lung cancer along with what type of NSCLC you're diagnosed with. There are three primary types: adenocarcinoma, squamous cell carcinoma, and ...

Background: Cancer stem cells (CSCs) have been characterized to be responsible for multidrug resistance, metastasis, recurrence, and immunosuppressive in head and neck squamous cell carcinoma (HNSCC).

In this study, brownish epithelium was significantly associated with a diagnosis of HGIN or invasive cancer ... finding for the diagnosis of esophageal squamous neoplasias. The brownish coloration ...

Symptoms often include a painless neck lump and a sore throat. The main risk factors for tonsil cancer are smoking, drinking alcohol and infection with the human papilloma virus (HPV). Most tonsil ...

A total of 68 superficial esophageal neoplasias in 58 patients treated by endoscopic resection at the Osaka Medical Center for Cancer and Cardiovascular Diseases from May 2011 to March 2012 were ...